Indena SpA

About Indena SpA

Indena is very well known as a leading API contract developer and supplier.
Funded in Italy in 1921, the company is privately owned and serving the global markets with its 4 manufacturing plants.

The technological offer covers APIs of botanical, fermentation and synthetic origin, with a unique expertise for HPAPIs. Capitalizing on its twenty year experience in handling HPAPIs development and manufacturing at large industrial scale, an additional new kilolab (LK2), designed to handle the production of highly toxic substances endowed with an OEL of 20 ng/m3 (including toxins fo...

  • CE
  • FDA
  • GMP
  • ISO
  • Other
  • IT
  • 2015
    On CPHI since
  • 5
  • 500 - 999
Company types
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Contact info
Meet us at

CPHI & PMEC China 2023

Shanghai New International Expo Center
19 - 21 June 2023

CPHI Barcelona 2023

Fira Barcelona Gran Via, Spain
24-26 October 2023

Products from Indena SpA (5)

  • Cannabidiol (from hemp)

    Product Cannabidiol (from hemp)

    Natural cannabinoid from hemp
  • Cascara Sagrada Extract

    Product Cascara Sagrada Extract

    Indena SpA offers a wide range of pharmaceutical products which includes cascara sagrada extract. Botanical origin: rhamnus purshiana dc. bark. Biological activity: laxative. Contact us for more information.
  • Centella Asiatica Selected Triterpenes

    Product Centella Asiatica Selected Triterpenes

    Indena SpA offers a wide range of pharmaceutical products which includes centella asiatica selected triterpenes. Botanical origin: centella asiatica (l.) urban leaf. Biological activity: cicatrizing-trophodermic. Contact us for more information.
  • Chamomile Extract

    Product Chamomile Extract

    Indena SpA offers a wide range of pharmaceutical products which includes chamomile extract. Botanical origin: matricaria recutita l. flowering head, leave. Biological activity: spasmolytic. Contact us for more information.
  • Colchicine Micronized

    Product Colchicine Micronized

    Colchicine micronized. Botanical origin: gloriosa superba l. seed. Biological activity: antigout.

Indena SpA Resources (6)

  • Whitepaper CDMO services

    We have a unique expertise in developing and manufacturing HPAPIs. The company is equipped with kilolabs (for clinical and small commercial batches) and large industrial suite for HPAPIs with an OEL>20 ng/m3.
  • Video Indena at CPHI WorldWide 2017

    Have a look at the interview with Indena and their BD & Licensing Director, Stefano Togni. In the interview she talks about, among other things, their facilities around the world and what updates they have to offer.
  • Podcast Podcast: HPAPI Manufacturing: Challenges, Solutions & Innovations

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. Growth in the highly potent active pharmaceutical ingredients segment means there is strong demand for specialist outsourcing solutions for their manufacture. CDMOs don’t just need to have the right equipment and facilities; they also need to convince sponsors that they possess the in-depth knowledge of safety practices and containment technology. In this CPHI Worldwide podcast with Carlo Aloni, Production and Process Technology Director at Indena, we looked at the various challenges of HPAPI production, the latest innovative technologies and what Indena is currently working towards in this highly promising growth sector.
  • Podcast Podcast - CDMO Capabilities in Challenging Times

    This podcast was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. When a pharmaceutical sponsor company decides it wishes to outsource vital functions such as manufacturing, drug development, and formulation, they are looking for several key qualities in a service provider. CDMOs need to provide flexibility, collaboration and innovation, as well as the ability to continuously evolve their offering. In this CPHI Worldwide podcast with Stefano Togni, Business Development Director at Indena, we explore how CDMOs are adapting to changing market conditions amid these challenging times.
  • Podcast Podcast: Resilience and Sustainability – 100 years of Indena and Reflections on 2021

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. 2021 has been the second year of a very difficult and challenging global pandemic, to which the pharmaceutical industry has had to respond with resilience and flexibility. Coincidentally, it is also the centenary year of API contract developer and supplier, Indena. In this CPHI Worldwide podcast with Francesca de Rensis, Marketing Director at Indena, we take a look back at the proud 100 years of history that have shaped the company into the international business it is today as well as examining the main supply chain challenges facing that have defined the year 2021.
  • Webinar Indena's Commitment to Sustainability: From Responsible Supply Chain Management to Smart Use of Energy, we aim to Protect Nature, People, and Business

    Indena is relentlessly working to generate a sustainable impact on its stakeholders, cultivating with care its own precious circle: Nature, Technology, and People. In terms of actual projects and actions, Indena's commitment in sustainability includes responsible supply chain management, a circular economy in product design, and very smart use of energy in its plants. As for energy use, which is linked to climate change, one of the most urgent global sustainability challenges, Indena has been working for years to reduce consumption, save energy, and achieve high levels of energy self-production. All the actions taken for sustainability allow Indena to be fully reliable in terms of business continuity and thus be a solid partner for all its clients.